Media Releases

2019

13/06/2019

PIQ Investor Presentation – 121 Tech Investment Hong Kong

07/06/2019

PromarkerD showcased at American Diabetes Association conference 2019

03/06/2019

Proteomics showcased PromarkerD at BIO Convention

22/02/2019

US patent for identifying drugs for abnormal kidney function

24/01/2019

PromarkerD US market update

2018

26/11/2018

Proteomics signs PromarkerD agreement with US big pharma

09/11/2018

PromarkerD kit version complete – Commercial release imminent

24/10/2018

Diabetic kidney disease test enters Europe & Export Award

17/10/2018

Proteomics receives $834k in R&D Tax Incentive

05/10/2018

Proteomics receives $928k from sale of shareholding in CPR

19/09/2018

Proteomics & Atturos partner to target diagnostics in Europe

12/09/2018

Proteomics to receive $928k from sale of shareholding in CPR

23/08/2018

Diagnostics Update – the Promarker pipeline

17/07/2018

Proteomics secures major contract – nears cash flow positive

22/06/2018

Proteomics at ADA Diabetes Conference

1
2
3
4
5
6
7
8
9